| dc.contributor | Universidade Estadual Paulista (UNESP) | |
| dc.creator | Olivera, María Eugenia | |
| dc.creator | Uema, Sonia Andrea Naeko | |
| dc.creator | Romañuk, Carolina Beatriz | |
| dc.creator | Caffaratti, Mariana | |
| dc.creator | Mastroianni, Patricia de Carvalho | |
| dc.creator | Varallo, Fabiana Rossi | |
| dc.creator | Vazquez, Marta | |
| dc.creator | Fagiolino, Pietro | |
| dc.creator | Maldonado, Cecilia | |
| dc.creator | Vega, Elena María | |
| dc.creator | Galvan, Zully Vera | |
| dc.creator | Maidanag, Mabel | |
| dc.creator | Acostag, Patricia | |
| dc.creator | Rivero, Roxana | |
| dc.creator | Barros, Carolina | |
| dc.creator | Fontana, Daniela | |
| dc.date | 2016-01-28T16:56:41Z | |
| dc.date | 2016-10-25T21:28:56Z | |
| dc.date | 2016-01-28T16:56:41Z | |
| dc.date | 2016-10-25T21:28:56Z | |
| dc.date | 2014 | |
| dc.date.accessioned | 2017-04-06T09:50:33Z | |
| dc.date.available | 2017-04-06T09:50:33Z | |
| dc.identifier | Pharmaceuticals Policy and Law, v. 16, p. 289-312, 2014. | |
| dc.identifier | 1389-2827 | |
| dc.identifier | http://hdl.handle.net/11449/133808 | |
| dc.identifier | http://acervodigital.unesp.br/handle/11449/133808 | |
| dc.identifier | 10.3233/PPL-140390 | |
| dc.identifier | 4160558780902988 | |
| dc.identifier | http://dx.doi.org/10.3233/PPL-140390 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/944337 | |
| dc.description | Pharmacovigilance is responsible for monitoring the safety of medicines in normal clinical use andduring clinical trials. Legal requirements for pharmacovigilance in some Latin American countries (Argentina, Brazil, Chile, Paraguay and Uruguay) were reviewed. Disparities in the legal framework among the countries are observed being those for marketing authorization holders one of the most evident. Theactive rol of the universities and drug information centers for/of pharmacovilance seems to be a positivecommon point. Legal requirements regarding pharmacovigilance of biosimilar medicines, is still a pointto be developed. | |
| dc.language | eng | |
| dc.publisher | Network of Centres for Study of Pharmaceutical Law | |
| dc.relation | Pharmaceuticals Policy and Law | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Drug information services | |
| dc.subject | Product surveillance | |
| dc.subject | Postmarketing | |
| dc.subject | Pharmaceutical industry | |
| dc.subject | Pub-lic health | |
| dc.title | Regulatory issues on pharmacovigilance in Latin American countries | |
| dc.type | Otro | |
